Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  Ibraim, Izabela Coimbra ^a   De Assis, Rafael Ramiro ^a   Pessoa, Natália Lima ^a   Campos, Marco Antônio ^a   Melo, Maria Norma ^b   Turco, Salvatore Joseph ^c   Soares, Rodrigo Pedro ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Leishmania braziliensis; Leishmania infantum; Lipophosphoglycan (LPG); Macrophage modulation

Indexed keywords

GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; LIPOPHOSPHOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; GLYCOSPHINGOLIPID; NITRITE;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; IMMUNOSTIMULATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROMASTIGOTE; SIGNAL TRANSDUCTION; SPECIES COMPARISON; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; CHO CELL LINE; CRICETULUS; GENE EXPRESSION REGULATION; HAMSTER; HOST PARASITE INTERACTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PARASITOLOGY; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

INVERTEBRATA; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; MURINAE; MUS; VERTEBRATA;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GLYCOSPHINGOLIPIDS; HOST-PARASITE INTERACTIONS; IMMUNITY, INNATE; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NITRITES;

EID: 84874586377     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-54     Document Type: Article

References (47)

1. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Grimaldi G Jr, Tesh RB, McMahon-Pratt D, Am J Trop Med Hyg 1989 41 687 725 2701633 (Pubitemid 20022744)
2. Leishmaniasis. Herwaldt BL, Lancet 1999 354 1191 1199 10.1016/S0140-6736(98)10178-2 10513726 (Pubitemid 29460458)
3. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. Evans TG, Thai L, Granger DL, Hibbs JB Jr, J Immunol 1993 151 907 915 8335918 (Pubitemid 23215756)
4. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Gazzinelli RT, Ropert C, Campos MA, Immunol Rev 2004 201 9 25 10.1111/j.0105-2896.2004.00174.x 15361229 (Pubitemid 39318440)
5. Regulation of interleukin 2-dependent growth responses by glycosylphosphatidylinositol molecules. Merida I, Pratt JC, Gaulton GN, Proc Natl Acad Sci U S A 1990 87 9421 9425 10.1073/pnas.87.23.9421 2147515 (Pubitemid 120030638)
6. The role of glycosyl-phosphoinositides in hormone action. Saltiel AR, J Bioenerg Biomembr 1991 23 29 41 1849135
7. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY, J Immunol 1999 163 6403 6412 10586030
8. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Tachado SD, Gerold P, Schwarz R, Novakovic S, McConville M, Schofield L, Proc Natl Acad Sci U S A 1997 94 4022 4027 10.1073/pnas.94.8.4022 9108098 (Pubitemid 27180492)
9. Intraspecies variation in trypanosoma cruzi GPI-Mucins: biological activities and differential expression of alpha-galactosyl residues. Soares RP, Torrecilhas AC, Assis RR, Rocha MN, Moura ECFA, Freitas GF, Murta SM, Santos SL, Marques AF, Almeida IC, Romanha AJ, Am J Trop Med Hyg 2012 87 87 96 10.4269/ajtmh.2012.12-0015 22764297
10. A role for insect galectins in parasite survival. Kamhawi S, Ramalho-Ortigao M, Pham VM, Kumar S, Lawyer PG, Turco SJ, Barillas-Mury C, Sacks DL, Valenzuela JG, Cell 2004 119 329 341 10.1016/j.cell.2004.10.009 15543683 (Pubitemid 39423836)
11. Glycoconjugates in Leishmania infectivity. Descoteaux A, Turco SJ, Biochim Biophys Acta 1999 1455 341 352 10.1016/S0925-4439(99)00065-4 10571023 (Pubitemid 29435999)
12. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Guimaraes-Costa AB, Nascimento MT, Froment GS, Soares RP, Morgado FN, Conceicao-Silva F, Saraiva EM, Proc Natl Acad Sci U S A 2009 106 6748 6753 10.1073/pnas.0900226106 19346483
13. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. Descoteaux A, Turco SJ, Sacks DL, Matlashewski G, J Immunol 1991 146 2747 2753 1707920
14. Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation and translocation of protein kinase C. Olivier M, Brownsey RW, Reiner NE, Proc Natl Acad Sci U S A 1992 89 7481 7485 10.1073/pnas.89.16.7481 1323839
15. Leishmania donovani lipophosphoglycan inhibits phagosomal maturation via action on membrane rafts. Winberg ME, Holm A, Sarndahl E, Vinet AF, Descoteaux A, Magnusson KE, Rasmusson B, Lerm M, Microbes Infect 2009 11 215 222 10.1016/j.micinf.2008.11.007 19070677
16. Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Lodge R, Descoteaux A, Eur J Immunol 2006 36 2735 2744 10.1002/eji.200636089 16955522 (Pubitemid 44608457)
17. Exploitation of the complement system by Leishmania promastigotes. Brittingham A, Mosser DM, Parasitol Today 1996 12 444 447 10.1016/0169-4758(96) 10067-3 15275279 (Pubitemid 26353795)
18. Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2. Vivarini Ade C, Pereira Rde M, Teixeira KL, Calegari-Silva TC, Bellio M, Laurenti MD, Corbett CE, Gomes CM, Soares RP, Silva AM, FASEB J 2011 25 4162 4173 10.1096/fj.11-185165 21846836
19. Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. Luz NF, Andrade BB, Feijo DF, Araujo-Santos T, Carvalho GQ, Andrade D, Abanades DR, Melo EV, Silva AM, Brodskyn CI, J Immunol 2012 188 4460 4467 10.4049/jimmunol.1103072 22461696
20. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proudfoot L, Nikolaev AV, Feng GJ, Wei WQ, Ferguson MA, Brimacombe JS, Liew FY, Proc Natl Acad Sci U S A 1996 93 10984 10989 10.1073/pnas.93.20. 10984 8855295 (Pubitemid 26333104)
21. Leishmania infantum: lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. Coelho-Finamore JM, Freitas VC, Assis RR, Melo MN, Novozhilova N, Secundino NF, Pimenta PF, Turco SJ, Soares RP, Int J Parasitol 2011 41 333 342 10.1016/j.ijpara.2010.10.004 21118695
22. Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure. Assis RR, Ibraim IC, Noronha FS, Turco SJ, Soares RP, PLoS Negl Trop Dis 2012 6 1543 10.1371/journal.pntd.0001543 22389743
23. Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Soares RP, Macedo ME, Ropert C, Gontijo NF, Almeida IC, Gazzinelli RT, Pimenta PF, Turco SJ, Mol Biochem Parasitol 2002 121 213 224 10.1016/S0166-6851(02)00033-6 12034455 (Pubitemid 34603406)
24. Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesis. Soares RP, Cardoso TL, Barron T, Araujo MS, Pimenta PF, Turco SJ, Int J Parasitol 2005 35 245 253 10.1016/j.ijpara.2004.12. 008 15722076 (Pubitemid 40250208)
25. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. McConville MJ, Ferguson MA, Biochem J 1993 294 Pt 2 305 324 8373346 (Pubitemid 23268825)
26. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. Orlandi PA Jr, Turco SJ, J Biol Chem 1987 262 10384 10391 3611065
27. A colorimetric method for the determination of sugars. Dubois M, Gilles K, Hamilton JK, Rebers PA, Smith F, Nature 1951 168 167 14875033
28. Stimulus (polyphenol, IFN-gamma, LPS)-dependent nitric oxide production and antileishmanial effects in RAW 264.7 macrophages. Kolodziej H, Radtke OA, Kiderlen AF, Phytochemistry 2008 69 3103 3110 10.1016/j.phytochem.2007.11.012 18164321
29. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT, J Biol Chem 1999 274 33419 33425 10.1074/jbc.274.47.33419 10559223 (Pubitemid 129511647)
30. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-alpha, signal transduction. Delude RL, Yoshimura A, Ingalls RR, Golenbock DT, J Immunol 1998 161 3001 3009 9743364 (Pubitemid 28425725)
31. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Drapier JC, Wietzerbin J, Hibbs JB Jr, Eur J Immunol 1988 18 1587 1592 10.1002/eji.1830181018 3142779 (Pubitemid 18269344)
32. An analysis of variance test for normality (complete samples). Shapiro S, Wilk M, Biometrika 1950 52 591 611
33. Leishmaniasis: complexity at the host-pathogen interface. Kaye P, Scott P, Nat Rev Microbiol 2011 9 604 615 10.1038/nrmicro2608 21747391
34. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. de Veer MJ, Curtis JM, Baldwin TM, DiDonato JA, Sexton A, McConville MJ, Handman E, Schofield L, Eur J Immunol 2003 33 2822 2831 10.1002/eji.200324128 14515266 (Pubitemid 37337148)
35. Glycoconjugates in New World species of Leishmania: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts. de Assis RR, Ibraim IC, Nogueira PM, Soares RP, Turco SJ, Biochim Biophys Acta 1820 2012 1354 1365
36. The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. Acosta-Serrano A, Almeida IC, Freitas-Junior LH, Yoshida N, Schenkman S, Mol Biochem Parasitol 2001 114 143 150 10.1016/S0166-6851(01) 00245-6 11378194 (Pubitemid 32510751)
37. Innate immune response in Th1- and Th2-dominant mouse strains. Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A, Shock 2004 22 460 466 10.1097/01.shk.0000142249.08135.e9 15489639 (Pubitemid 39472571)
38. Exploring the full spectrum of macrophage activation. Mosser DM, Edwards JP, Nat Rev Immunol 2008 8 958 969 10.1038/nri2448 19029990
39. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE, Parasite Immunol 2009 31 423 431 10.1111/j.1365-3024.2009.01116.x 19646206
40. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions. Mahoney AB, Sacks DL, Saraiva E, Modi G, Turco SJ, Biochemistry 1999 38 9813 9823 10.1021/bi990741g 10433687 (Pubitemid 29374933)
41. Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice. Vargas-Inchaustegui DA, Tai W, Xin L, Hogg AE, Corry DB, Soong L, Infect Immun 2009 77 2948 2956 10.1128/IAI.00154-09 19364834
42. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Becker I, Salaiza N, Aguirre M, Delgado J, Carrillo-Carrasco N, Kobeh LG, Ruiz A, Cervantes R, Torres AP, Cabrera N, Mol Biochem Parasitol 2003 130 65 74 10.1016/S0166-6851(03)00160-9 12946842 (Pubitemid 37289124)
43. Toll-like receptors and leishmaniasis. Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V, Infect Immun 2008 76 866 872 10.1128/IAI.01090-07 18070909 (Pubitemid 351428044)
44. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Flandin JF, Chano F, Descoteaux A, Eur J Immunol 2006 36 411 420 10.1002/eji.200535079 16369915 (Pubitemid 43257464)
45. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Kropf P, Freudenberg MA, Modolell M, Price HP, Herath S, Antoniazi S, Galanos C, Smith DF, Muller I, Infect Immun 2004 72 1920 1928 10.1128/IAI.72.4.1920-1928.2004 15039311 (Pubitemid 38419902)
46. Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Junghae M, Raynes JG, Infect Immun 2002 70 5026 5035 10.1128/IAI.70.9.5026-5035.2002 12183549
47. Visceral leishmaniasis (kala-azar): challenges ahead. Singh RK, Pandey HP, Sundar S, Indian J Med Res 2006 123 331 344 16778314 (Pubitemid 43905573)